Traphagen Investment Advisors Llc
Source: SEC Form 13F · as of Mar 2026Traphagen Investment Advisors Llc holds 15 biotech & pharma companies tracked by BioSniper, totaling $10.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$10.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 9,710 | $2.4M |
| ABBVAbbVie Inc. | 9,611 | $2.1M |
| LLYELI LILLY & Co | 1,262 | $1.2M |
| PMPhilip Morris International Inc | 5,641 | $933K |
| MRKMerck & Co., Inc. | 6,615 | $796K |
| REGNREGENERON PHARMACEUTICALS, INC. | 985 | $761K |
| PFEPFIZER INC | 22,577 | $634K |
| AMGNAMGEN INC | 1,361 | $479K |
| ABTABBOTT LABORATORIES | 4,227 | $434K |
| GILDGILEAD SCIENCES, INC. | 2,140 | $298K |
| BMYBRISTOL MYERS SQUIBB CO | 3,491 | $212K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 38,962 | $137K |
| LUCDLucid Diagnostics Inc. | 29,295 | $34K |
| RANIRani Therapeutics Holdings, Inc. | 22,024 | $16K |
| OPKOPKO HEALTH, INC. | 11,680 | $13K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.